Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,404,755
-$1,612,424 QoQ
Shares Held
671,843
0.0% QoQ
Ownership
0.768%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#30
of 182 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vivo Capital, LLC holds $1,052,388,129 across 43 Biotechnology names. OLMA ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $95,015,558 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
271,116 | $90,766,925 | |
| 3 | ERAS |
Erasca, Inc.
|
4,127,412 | $75,614,187 | |
| 4 | AVBP |
ArriVent BioPharma, Inc.
|
1,682,097 | $58,436,049 | |
| 5 | ABVX |
Abivax S.A.
|
414,899 | $55,289,440 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
1,379,769 | $43,131,578 | |
| 7 | CRVS |
Corvus Pharmaceuticals, Inc.
|
2,805,816 | $41,918,891 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
557,172 | $39,113,474 |
All Filings in OLMA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,404,755 | 671,843 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,017,179 | 671,843 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $16,796,075 | 671,843 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,742,388 | 1,505,862 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,414,972 | 1,505,862 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,662,041 | 1,505,862 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,779,175 | 1,505,862 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,979,992 | 1,505,862 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,273,477 | 1,873,704 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,210,329 | 1,873,704 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $26,288,067 | 1,873,704 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $23,140,244 | 1,873,704 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $12,093,617 | 1,339,271 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,862,617 | 1,689,515 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,139,311 | 1,689,515 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,663,061 | 1,689,515 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,876,326 | 1,689,515 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,197,333 | 1,689,515 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $15,813,860 | 1,689,515 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $34,135,127 | 1,238,575 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $34,655,328 | 1,238,575 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $41,095,918 | 1,238,575 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $59,550,686 | 1,238,575 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||